Literature DB >> 10440607

The effect of faecal enema on five microflora-associated characteristics in patients with antibiotic-associated diarrhoea.

A Gustafsson1, A Berstad, S Lund-Tønnesen, T Midtvedt, E Norin.   

Abstract

BACKGROUND: Patients with antibiotic-associated diarrhoea (AAD) show significant disturbances in short-chain fatty acid pattern. In the present study five more microflora-associated characteristics (MACs) were investigated before and after administration of an enema containing faecal microflora from a healthy person on a Western diet.
METHODS: The functions of the microflora were determined with gas chromatography, electrophoresis, and spectrophotometry.
RESULTS: The conversion of cholesterol to coprostanol and the concentration of urobilinogen and trypsin were significantly reduced in comparison with healthy persons. The pattern of mucin was altered, but beta-aspartylglycine remained the same as in healthy persons. Enema treatment influenced these functions to different extents.
CONCLUSION: Most MACs were significantly disturbed in patients with AAD. Administration of a human faecal enema modified these changes and relieved diarrhoea, usually within 4 days.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10440607     DOI: 10.1080/003655299750026038

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  13 in total

Review 1.  Fecal microbiota transplantation and emerging applications.

Authors:  Thomas J Borody; Alexander Khoruts
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-12-20       Impact factor: 46.802

Review 2.  Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook.

Authors:  Colleen R Kelly; Stacy Kahn; Purna Kashyap; Loren Laine; David Rubin; Ashish Atreja; Thomas Moore; Gary Wu
Journal:  Gastroenterology       Date:  2015-05-15       Impact factor: 22.682

3.  Quantitative PCR assays for mouse enteric flora reveal strain-dependent differences in composition that are influenced by the microenvironment.

Authors:  A Deloris Alexander; Roger P Orcutt; Janell C Henry; Joseph Baker; Anika C Bissahoyo; David W Threadgill
Journal:  Mamm Genome       Date:  2006-11-07       Impact factor: 2.957

4.  Fresh Versus Frozen Stool for Fecal Microbiota Transplantation-Assessment by Multimethod Approach Combining Culturing, Flow Cytometry, and Next-Generation Sequencing.

Authors:  Jaroslaw Bilinski; Mikolaj Dziurzynski; Pawel Grzesiowski; Edyta Podsiadly; Anna Stelmaszczyk-Emmel; Tomasz Dzieciatkowski; Karol Lis; Martyna Tyszka; Krzysztof Ozieranski; Łukasz Dziewit; Grzegorz W Basak
Journal:  Front Microbiol       Date:  2022-07-01       Impact factor: 6.064

5.  Fecal microbiota transplantation in relapsing Clostridium difficile infection.

Authors:  Faith Rohlke; Neil Stollman
Journal:  Therap Adv Gastroenterol       Date:  2012-11       Impact factor: 4.409

Review 6.  Fecal microbiota transplantation for management of Clostridium difficile infection.

Authors:  Chetana Vaishnavi
Journal:  Indian J Gastroenterol       Date:  2014-04-20

Review 7.  Probiotics and irritable bowel syndrome.

Authors:  Cong Dai; Chang-Qing Zheng; Min Jiang; Xiao-Yu Ma; Li-Juan Jiang
Journal:  World J Gastroenterol       Date:  2013-09-28       Impact factor: 5.742

8.  Can microbiota transplantation abrogate murine colonization resistance against Campylobacter jejuni?

Authors:  M M Heimesaat; R Plickert; A Fischer; U B Göbel; S Bereswill
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2013-03-13

Review 9.  Fecal Microbiota Therapy for Clostridium difficile Infection: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2016-07-01

10.  Clostridium difficile-associated Enteric Disease.

Authors:  John G. Bartlett
Journal:  Curr Infect Dis Rep       Date:  2002-12       Impact factor: 3.663

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.